PHARMACEUTICAL ECONSULTING A/S

CVR 30815378 · Public limited company (A/S) · Active · Low risk

PHARMACEUTICAL ECONSULTING A/S is a Public limited company (A/S), founded on , based in Glostrup. The company is registered in the industry andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.. Our model estimates a bankruptcy risk of 0.2% over the next 12 months, which is 0.2 times the average for Danish companies. 18 annual reports have been published, of which 7 more than six months after the end of the financial year. The latest annual report (30 Sep 2025) shows equity of DKK 5.2m and a net result of DKK -1.1m.

Bankruptcy risk for PHARMACEUTICAL ECONSULTING A/S

0.2%
probability of bankruptcy within 12 months
Low risk

0.2 × the average (1.41%) · higher risk than 49% of active Danish companies

Lowest riskHighest risk

Increases the risk

Number of CEOs0 · bankruptcy rate 12.7%1.4×
RegionHovedstaden · bankruptcy rate 11.6%1.3×
Other companies at the same address100+ · bankruptcy rate 11.5%1.3×
CEO changes1 · bankruptcy rate 11.4%1.3×
CEO's other companies0 · bankruptcy rate 10.9%1.2×
Share of late annual reports25%–50% · bankruptcy rate 10.6%1.2×
Loss for the yearYes · bankruptcy rate 10.3%1.2×
Employees (latest year)2–5 · bankruptcy rate 10.3%1.2×

Reduces the risk

Reinstated after compulsory dissolutionYes · bankruptcy rate 0.0%0.00×
Equity vs. share capital5+× · bankruptcy rate 2.5%0.28×
Auditor's statementExtended review · bankruptcy rate 2.9%0.33×
Published annual reports10+ · bankruptcy rate 3.0%0.35×
Time at current address5+ yrs · bankruptcy rate 3.1%0.35×
Age (years)10–20 yrs · bankruptcy rate 3.9%0.45×
Company typeA/S · bankruptcy rate 4.4%0.50×
Gross profit growth10%–30% · bankruptcy rate 4.5%0.51×

The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.

Company details

CVR number
30815378
Status
Active
Company type
Public limited company (A/S)
Founded
(19 years)
Address
Naverland 2, 10.
2600 Glostrup
Municipality
Albertslund
Industry
Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n. (749990)
Bankruptcies in the industry: Andre liberale, videnskabelige og tekniske tjenesteydelser i.a.n.
Share capital
DKK 500k
Employees
4 (2018)
Auditor
Optimal Revision Godkendt Revisionsvirksomhed
Audit opted out
No

Warning signs

Annual reports filed late8 of 18
Missing annual reportNo
Negative equityNo
Equity ratio48.6%
Current ratio193%
Moves (last 2 years)0
CEO changes in total1
CEO's previous bankruptcies0
Other companies at the address334
Going-concern uncertaintyNo

Financials and key figures

Financial year20252024
Gross profitDKK 6.1mDKK 5.5m
Net profitDKK -1.1mDKK -644k
EquityDKK 5.2mDKK 6.2m
Total assetsDKK 10.6mDKK 8.8m
CashDKK 935k–
Short-term debtDKK 5.3m–
Avg. employees0–

Latest annual report: Reporting class B · auditor's statement: Erklæring om udvidet gennemgang · Optimal Revision Godkendt Revisionsvirksomhed.

Filed annual reports

Reporting periodPublishedDays after period end
1 Oct 2024 – 30 Sep 2025199 Late
1 Oct 2023 – 30 Sep 2024193 Late
1 Oct 2022 – 30 Sep 2023208 Late
1 Oct 2021 – 30 Sep 2022188 Late
1 Oct 2020 – 30 Sep 2021167
1 Oct 2019 – 30 Sep 2020157
1 Oct 2018 – 30 Sep 2019165
1 Oct 2017 – 30 Sep 2018151
1 Oct 2016 – 30 Sep 2017151
1 Oct 2015 – 30 Sep 2016150
1 Oct 2014 – 30 Sep 2015294 Late
1 Oct 2013 – 30 Sep 2014178
1 Oct 2012 – 30 Sep 2013209 Late
1 Oct 2011 – 30 Sep 2012182
1 Oct 2010 – 30 Sep 2011192 Late
1 Oct 2009 – 30 Sep 2010158
1 Oct 2008 – 30 Sep 2009167
3 Sep 2007 – 30 Sep 2008153

The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.

Management, owners and auditor

RoleNameFromTo
CEOSteen Otto Rugaard
BoardHanne Laurberg OlesenCurrent
BoardSteen Otto RugaardCurrent
BoardPernille Laurberg RugaardCurrent
BoardHanne Laurberg Olesen
BoardSteen Otto Rugaard
BoardJens Christian Pii Olesen
BoardPernille Laurberg Rugaard
BoardHanne Laurberg Olesen
Owner (100%)RUGAARD HOLDING ApSCurrent
AuditorOptimal Revision Godkendt RevisionsvirksomhedCurrent
AuditorOptimal Revision Godkendt Revisionsvirksomhed
FounderRUGAARD HOLDING ApSCurrent

The CEOs' other companies

Steen Otto Rugaard – 1 other companies

Address history (2 moves)

Naverland 2, 10., 2600 Glostrup
Naverland 2, 10., 2600 Glostrup
Tørveslettevej 10, 2765 Smørum

Employees per year

Number of employees at PHARMACEUTICAL ECONSULTING A/S per year472011: 620112012: 420122013: 420132014: 720142015: 620152016: 520162017: 420172018: 42018

Other companies at the same address

Similar companies in Albertslund

Questions and answers about PHARMACEUTICAL ECONSULTING A/S

Has PHARMACEUTICAL ECONSULTING A/S gone bankrupt?

No, PHARMACEUTICAL ECONSULTING A/S is not registered as bankrupt in the CVR register. Its status is: active.

What is the bankruptcy risk of PHARMACEUTICAL ECONSULTING A/S?

Our model estimates a bankruptcy risk of 0.2% over the next 12 months (low risk), which is 0.2 times the average for Danish companies.

Who is the auditor of PHARMACEUTICAL ECONSULTING A/S?

PHARMACEUTICAL ECONSULTING A/S most recently used Optimal Revision Godkendt Revisionsvirksomhed.

When was PHARMACEUTICAL ECONSULTING A/S founded?

PHARMACEUTICAL ECONSULTING A/S was founded on 3 September 2007.

What is the equity of PHARMACEUTICAL ECONSULTING A/S?

Equity was DKK 5.2m according to the annual report for the period ending 30 September 2025.

Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.